Related stories
AstraZeneca Wins Two US Drug Approvals
The approvals cover expanded Imfinzi use for bladder cancer and a first-of-its-kind therapy for a rare muscle-weakening disorder.
M impact | EQUITY | Nov 16, 2026, 07:59 AM UTC
AstraZeneca Wins US Approval for Expanded Imfinzi Use and Rare-Disease Therapy
M impact | EQUITY | Nov 16, 2026, 07:59 AM UTC
Belrise Industries shares jump 12% to one-month high after Q2 results
Shares rose more than 12% to Rs 241.50 in Monday trading, making Belrise the Nifty 500’s top performer. The company reported sharply higher consolidated net profit for the quarter
M impact | EQUITY | Nov 16, 2026, 07:51 AM UTC
Mubadala, Centerbridge to acquire Canaccord Wealth for $1.54 billion
M impact | EQUITY | Nov 16, 2026, 07:50 AM UTC
Thalassa Holdings Was Approached by Private Equity Consortium Seeking Newmark
M impact | EQUITY | Nov 16, 2026, 07:46 AM UTC
REUTERS POLL-BANK INDONESIA 7-DAY REVERSE REPO RATE SEEN AT 6.00% OR HIGHER BY END-2026, SAY 16 OF 22 ECONOMISTS
REUTERS POLL-BANK INDONESIA 7-DAY REVERSE REPO RATE SEEN AT 6.00% OR HIGHER BY END-2026, SAY 16 OF 2
L impact | EQUITY | Nov 16, 2026, 07:40 AM UTC